🇯🇵 Japan Country × Condition
amyotrophic lateral sclerosis als Clinical Trials in Japan
Active clinical trials for amyotrophic lateral sclerosis als with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT07257302
Recruiting
Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis
Enrollment
15 pts
Country
🇯🇵 Japan
National Center of Neurology and Ps...
View Trial → NCT06351592 Phase 1, Phase 2
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Enrollment
54 pts
Country
🇯🇵 Japan
Regeneron Pharmaceuticals
View Trial → Frequently Asked Questions
How many amyotrophic lateral sclerosis als clinical trials are active in Japan?
There are currently 2 active clinical trials for amyotrophic lateral sclerosis als with sites in Japan, of which 2 are actively recruiting patients.
How can I join a amyotrophic lateral sclerosis als clinical trial in Japan?
To join a amyotrophic lateral sclerosis als clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are amyotrophic lateral sclerosis als trials in Japan?
Active amyotrophic lateral sclerosis als trials in Japan span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology